Lipopolysacchride-treated mammary carcinomas secrete proinflammatory chemokines and exhibit reduced growth rates in vivo, but not in vitro.
about
Lipopolysacchride-treated mammary carcinomas secrete proinflammatory chemokines and exhibit reduced growth rates in vivo, but not in vitro.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Lipopolysacchride-treated mamm ...... tes in vivo, but not in vitro.
@en
Lipopolysacchride-treated mamm ...... tes in vivo, but not in vitro.
@nl
type
label
Lipopolysacchride-treated mamm ...... tes in vivo, but not in vitro.
@en
Lipopolysacchride-treated mamm ...... tes in vivo, but not in vitro.
@nl
prefLabel
Lipopolysacchride-treated mamm ...... tes in vivo, but not in vitro.
@en
Lipopolysacchride-treated mamm ...... tes in vivo, but not in vitro.
@nl
P2093
P2860
P1476
Lipopolysacchride-treated mamm ...... tes in vivo, but not in vitro.
@en
P2093
A B Huggins
C M O'Donnell
J M Golden
M K Sajduk
Robert A Kurt
P2860
P304
P356
10.3109/08820130903177810
P577
2009-01-01T00:00:00Z